Genetic testing should be used to help doctors spot high-risk cases of myeloma and enable targeted treatments, say researchers from the University of Leeds and The Institute of Cancer Research.

Researchers have discovered and analysed a rare but serious side effect of an innovative form of blood cancer therapy.

Yashoda Hospital addresses rising blood cancer cases in India with advanced treatments at Deccan Hematolink 2.0 conference.

A father-of-two who is in remission from cancer is calling for the treatment which helped him to be made available on the NHS ...

Medically reviewed by Marla Anderson, MD Multiple myeloma is a rare type of blood cancer that starts in your plasma cells.

Black individuals had a 2-fold risk of cancer death related to prostate, myeloma, and stomach cancers compared with White ...

Cancer deaths among Black men and women in the United States have declined during the past decade in the United States, a new ...

The FDA has granted orphan drug designation to the oral agent OPN-6602 for the treatment of patients with relapsed or ...

Researchers have discovered and analyzed a rare but serious side effect of an innovative form of blood cancer therapy. The ...

A decades-long Minneapolis firefighter is now fighting another battle of his own. Six months ago, Mark Lakosky was diagnosed ...

Black men experienced the most significant relative decline in cancer deaths at nearly every age, compared to Black women and ...

Multiple myeloma is a rare blood cancer that develops in the plasma cells, which are white blood cells that help you fight infection by making antibodies. Multiple myeloma starts in the plasma ...